HK1243105A1 - 高活性的腫瘤抑制劑及其製法和應用 - Google Patents
高活性的腫瘤抑制劑及其製法和應用Info
- Publication number
- HK1243105A1 HK1243105A1 HK18102637.5A HK18102637A HK1243105A1 HK 1243105 A1 HK1243105 A1 HK 1243105A1 HK 18102637 A HK18102637 A HK 18102637A HK 1243105 A1 HK1243105 A1 HK 1243105A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparation
- high activity
- tumour inhibitor
- activity tumour
- inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410555112 | 2014-10-17 | ||
PCT/CN2015/092021 WO2016058547A1 (zh) | 2014-10-17 | 2015-10-15 | 高活性的肿瘤抑制剂及其制法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1243105A1 true HK1243105A1 (zh) | 2018-07-06 |
Family
ID=55746148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18102637.5A HK1243105A1 (zh) | 2014-10-17 | 2018-02-23 | 高活性的腫瘤抑制劑及其製法和應用 |
Country Status (5)
Country | Link |
---|---|
US (1) | US10441628B2 (zh) |
EP (1) | EP3208280A4 (zh) |
CN (1) | CN105524139B (zh) |
HK (1) | HK1243105A1 (zh) |
WO (1) | WO2016058547A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107446016A (zh) * | 2016-05-30 | 2017-12-08 | 上海交通大学 | 一种硬脂酸修饰的细胞穿膜肽及其制备与应用 |
CA3037369A1 (en) * | 2016-09-18 | 2018-03-22 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Yap1 inhibitors that target the interaction of yap1 with oct4 |
IT201800003398A1 (it) * | 2018-03-09 | 2019-09-09 | Aboca Spa Societa Agricola | Nuovi principi attivi per il trattamento di tumori |
SG11202008854TA (en) | 2018-03-14 | 2020-10-29 | H Lee Moffitt Cancer Center And Research Institute Inc | Yap1 inhibitors that target the interaction of yap1 with oct4 |
CN116135876A (zh) * | 2021-11-18 | 2023-05-19 | 上海市第十人民医院 | 一种多肽及其在制备抗肿瘤药物中的用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011501741A (ja) | 2007-10-04 | 2011-01-13 | エイジェンシー・フォー・サイエンス,テクノロジー・アンド・リサーチ(エイ・スター) | がんの診断および治療のためのtaz/wwtr1 |
GB0803352D0 (en) | 2008-02-22 | 2008-04-02 | Ntnu Technology Transfer As | Oligopeptidic compounds and uses thereof |
CN102136042B (zh) | 2010-01-26 | 2015-07-29 | 徐彦辉 | Yap-tead蛋白复合物的三维结构及其应用 |
WO2015022283A1 (en) | 2013-08-12 | 2015-02-19 | F. Hoffmann-La Roche Ag | Yap-tead inhibitors |
US10526385B2 (en) * | 2013-10-17 | 2020-01-07 | Bao Kang Biomedical Healthcare Inc | YAP protein inhibiting polypeptide and application thereof |
EP2868326A1 (en) | 2013-11-04 | 2015-05-06 | Université Pierre et Marie Curie (Paris 6) | Peptide inhibitors of TEAD/YAP-TAZ interaction |
-
2015
- 2015-10-15 WO PCT/CN2015/092021 patent/WO2016058547A1/zh active Application Filing
- 2015-10-15 US US15/519,753 patent/US10441628B2/en not_active Expired - Fee Related
- 2015-10-15 EP EP15850708.7A patent/EP3208280A4/en not_active Withdrawn
- 2015-10-15 CN CN201510672011.9A patent/CN105524139B/zh not_active Expired - Fee Related
-
2018
- 2018-02-23 HK HK18102637.5A patent/HK1243105A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2016058547A1 (zh) | 2016-04-21 |
US20170319648A1 (en) | 2017-11-09 |
EP3208280A1 (en) | 2017-08-23 |
US10441628B2 (en) | 2019-10-15 |
CN105524139A (zh) | 2016-04-27 |
EP3208280A4 (en) | 2018-10-10 |
CN105524139B (zh) | 2020-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL286316A (en) | New micro-dystrophins and related method of use | |
IL269462A (en) | MDM2 inhibitors and therapeutic methods that use them | |
IL250415B (en) | Antibodies against pd-l and methods of using them | |
FI3215147T3 (fi) | Hermostoa salpaavia norketamiiniyhdisteitä ja -menetelmiä | |
HK1253049A1 (zh) | 糖基相互作用化合物及其使用方法 | |
IL251988A0 (en) | Compounds acting on glycans and methods of using them | |
GB201404470D0 (en) | Therapeutic methods and materials | |
HK1244825A1 (zh) | Gas6抑制劑的抗纖維化活性 | |
PL3089971T3 (pl) | Związki i sposoby ich zastosowania | |
HK1243105A1 (zh) | 高活性的腫瘤抑制劑及其製法和應用 | |
SG11201704473WA (en) | New methods and uses | |
IL255530A (en) | Efflux-pump inhibitors and therapeutic uses thereof | |
GB201416293D0 (en) | Methods and preparations | |
HK1243342A1 (zh) | 化合物和方法 | |
HK1243077A1 (zh) | 呱啶基吡唑並嘧啶酮及其用途 | |
SG11201605915WA (en) | Furo-3-carboxamide derivatives and methods of use | |
ZA201606450B (en) | Compounds and their methods of use | |
IL247325A0 (en) | Therapeutic methods using noribogaine and related compounds | |
IL252191B (en) | Compositions and methods for modulating at2r activity | |
IL247797A0 (en) | A device for measuring sugar and a method for its use | |
GB201417248D0 (en) | Compostion and methods of treatment | |
IL248035A0 (en) | Database and the method of using it | |
GB201403697D0 (en) | Compounds and methods of use | |
GB201416797D0 (en) | Contianer and method of use thereof | |
GB201419559D0 (en) | Therapeutic compositions and methods |